TrialOrphanet journal of rare diseases2019

Effects of recombinant human growth hormone treatment on growth, body composition, and safety in infants or toddlers with Prader-Willi syndrome: a randomized, active-controlled trial.

Aram Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.